Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Shares Outstanding (2023 - 2025)

Historic Shares Outstanding for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $78.3 million.

  • CG Oncology's Shares Outstanding rose 1590.16% to $78.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.3 million, marking a year-over-year increase of 1590.16%. This contributed to the annual value of $76.2 million for FY2024, which is 135826.61% up from last year.
  • As of Q3 2025, CG Oncology's Shares Outstanding stood at $78.3 million, which was up 1590.16% from $76.2 million recorded in Q2 2025.
  • CG Oncology's Shares Outstanding's 5-year high stood at $78.3 million during Q3 2025, with a 5-year trough of $3.9 million in Q1 2023.
  • Over the past 3 years, CG Oncology's median Shares Outstanding value was $66.7 million (recorded in 2024), while the average stood at $47.8 million.
  • Its Shares Outstanding has fluctuated over the past 5 years, first surged by 162796.17% in 2024, then soared by 1435.95% in 2025.
  • Over the past 3 years, CG Oncology's Shares Outstanding (Quarter) stood at $5.2 million in 2023, then soared by 1358.27% to $76.2 million in 2024, then grew by 2.79% to $78.3 million in 2025.
  • Its last three reported values are $78.3 million in Q3 2025, $76.2 million for Q2 2025, and $76.2 million during Q1 2025.